Since identification of β2M as a dominating component of dialysis-associated amyloidosis[14], a lot of studies have been carried out in the past two decades to clarify the pathogenesis of the disease and aggregation mechanism of β2M [13,15–21]. The gene discussed is B2M; the disease is amyloidosis.